The Tumor Microenvironment Represses T Cell Mitochondrial Biogenesis to Drive Intratumoral T Cell Metabolic Insufficiency and Dysfunction
Overview
Authors
Affiliations
Although tumor-specific T cells recognize cancer cells, they are often rendered dysfunctional due to an immunosuppressive microenvironment. Here we showed that T cells demonstrated persistent loss of mitochondrial function and mass when infiltrating murine and human tumors, an effect specific to the tumor microenvironment and not merely caused by activation. Tumor-infiltrating T cells showed a progressive loss of PPAR-gamma coactivator 1α (PGC1α), which programs mitochondrial biogenesis, induced by chronic Akt signaling in tumor-specific T cells. Reprogramming tumor-specific T cells through enforced expression of PGC1α resulted in superior intratumoral metabolic and effector function. Our data support a model in which signals in the tumor microenvironment repress T cell oxidative metabolism, resulting in effector cells with metabolic needs that cannot be met. Our studies also suggest that modulation or reprogramming of the altered metabolism of tumor-infiltrating T cells might represent a potential strategy to reinvigorate dysfunctional T cells for cancer treatment.
The Emerging Role of CD8 T Cells in Shaping Treatment Outcomes of Patients with MDS and AML.
Tasis A, Spyropoulos T, Mitroulis I Cancers (Basel). 2025; 17(5).
PMID: 40075597 PMC: 11898900. DOI: 10.3390/cancers17050749.
Jacobs C, Peters F, Camerini E, Cretenet G, Rietveld J, Schomakers B Cell Mol Immunol. 2025; .
PMID: 40033083 DOI: 10.1038/s41423-025-01262-1.
How modulation of the tumor microenvironment drives cancer immune escape dynamics.
Shrestha P, Ghoreyshi Z, George J Sci Rep. 2025; 15(1):7308.
PMID: 40025156 PMC: 11873109. DOI: 10.1038/s41598-025-91396-z.
Energy metabolism in health and diseases.
Liu H, Wang S, Wang J, Guo X, Song Y, Fu K Signal Transduct Target Ther. 2025; 10(1):69.
PMID: 39966374 PMC: 11836267. DOI: 10.1038/s41392-025-02141-x.
Metabolic heterogeneity in tumor cells impacts immunology in lung squamous cell carcinoma.
Wang Q, Sun N, Zhang C, Kunzke T, Zens P, Feuchtinger A Oncoimmunology. 2025; 14(1):2457797.
PMID: 39924768 PMC: 11812363. DOI: 10.1080/2162402X.2025.2457797.